PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial [0.03%]
Martin Manley,Guilherme Nader-Marta,Ayça Arcay Ozturk et al.
Martin Manley et al.
Purpose: Radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) improves survival in metastatic castration-resistant prostate cancer. PSMA is also expressed in triple-negative breast cancer (TNBC), ...
Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting [0.03%]
Florian Rosar,Fadi Khreish,Caroline Burgard et al.
Florian Rosar et al.
Purpose: Several clinical and preclinical studies showed that ARPI medication such as enzalutamide increases the expression of PSMA in mCRPC patients and may potentially act as a sensitizer for PSMA RLT. In this study we ...
Contribution of quantitative I-123-ioflupane SPECT/CT to the differential diagnosis of dementia with lewy bodies [0.03%]
George Karun Kurian,Paolo Salvioni Chiabotti,Caroline Hall et al.
George Karun Kurian et al.
Purpose: Quantification of I-123-ioflupane uptake using modern SPECT/CT improves diagnostic accuracy for disorders affecting the nigrostriatal pathway. This study assessed whether absolute and relative standardized uptake...
Akram Al-Ibraheem,Anita Brink,Enrique Estrada-Lobato et al.
Akram Al-Ibraheem et al.
The Asia-Pacific region, comprising more than half of the world's population, includes both developed and developing nations. Understanding the current status of nuclear medicine (NM) and theranostics in this dynamic region is essential for...
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study [0.03%]
Irene Marini,Emilio Francesco Giunta,Silvia Nicolini et al.
Irene Marini et al.
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) remains a therapeutic challenge. Radioligand therapy (RLT) with 177Lu-PSMA-617 has shown promising efficacy. This study reports the first Italian prospectiv...
Comparison of multi-organ CT image segmentation tools for whole-body [18F]FDG-PET/CT clinical imaging [0.03%]
Cameron Wheeler,Phyo H Khaing,Eleonora D&#x;Arnese et al.
Cameron Wheeler et al.
Automated multi-organ segmentation looks to assist clinicians and researchers working with Positron Emission Tomography/Computed Tomography (PET/CT) imaging in streamlining the time-consuming, operator-dependent task of manual delineation. ...
A dual-tracer approach for enhanced nodal staging in prostate cancer: the role of [18F]FDG PET/CT for detecting [68 Ga]Ga-PSMA-11-negative metastases [0.03%]
前列腺癌增强淋巴结分期的双示踪剂方法：[18F]FDG PET/CT在检测[68Ga]Ga-PSMA-11阴性转移中的作用
Ruohua Chen,Yining Wang,Liang Dong et al.
Ruohua Chen et al.
Background and purpose: A subset of newly diagnosed prostate cancer patients harbor occult lymph node metastases (LNM) that are not detected by standard [68 Ga]Ga-PSMA-11 PET/CT, leading to potential understaging and subo...
Prognostic interplay between cardiac allograft vasculopathy and coronary vascular function by hybrid rubidium-82 PET/CT imaging in heart transplant population [0.03%]
心脏移植受者心血管同种异体移植物病与冠状血管功能的预后相互作用的混合态rizubium-PET/CT影像学研究
Roberta Assante,Emilia Zampella,Irene Mattucci et al.
Roberta Assante et al.
Purpose: We evaluated the interrelation of cardiac allograft vasculopathy (CAV) and both coronary artery calcium and coronary vascular function, as assessed rubidium-82 (82Rb) positron emission tomography (PET)/computed t...
Bilateral adrenal metastatic renal cell carcinoma revealed by CD70- and PSMA-targeted PET imaging [0.03%]
双侧肾上腺转移性肾细胞癌的双靶点（CD70和PSMA）显像PET检查结果显示
Herui Li,Zhiyong Quan,Weijun Wei et al.
Herui Li et al.
Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis [0.03%]
[68Ga]Ga-FAPI-46 PET在转移性尿路上皮癌患者中的潜在价值：一项多中心分析
Kim M Pabst,Sophie C Siegmund,Adrien Holzgreve et al.
Kim M Pabst et al.
Purpose: [68Ga]Ga-FAPI-46 has shown promise for urothelial cancer (UC) detection. This study evaluates its diagnostic value versus contrast-enhanced CT (ceCT) and 2-[18F]FDG PET in the largest bi-centric cohort to date. ...